Emerging & re-emerging infections in India: An overview

被引:0
|
作者
Dikid, T. [1 ]
Jain, S. K. [1 ]
Sharma, A. [2 ]
Kumar, A. [1 ]
Narain, J. P. [3 ]
机构
[1] Natl Ctr Dis Control, Div Epidemiol, Delhi, India
[2] WHO, Country Off India, New Delhi, India
[3] Natl Ctr Dis Control, Epidemiol & Epidem Intelligence Serv, Delhi 110054, India
关键词
Avian influenza; chikungunya; control; emerging infections; India; Nipah virus; plague; prevention; VIBRIO-CHOLERAE O139; CHANDIPURA VIRUS ENCEPHALITIS; RISK-FACTORS; OUTBREAK; PLAGUE; DISEASE; BENGAL; CHIKUNGUNYA; MAHARASHTRA; SEROGROUP;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The incidence of emerging infectious diseases in humans has increased within the recent past or threatens to increase in the near future. Over 30 new infectious agents have been detected worldwide in the last three decades; 60 per cent of these are of zoonotic origin. Developing countries such as India suffer disproportionately from the burden of infectious diseases given the confluence of existing environmental, socio-economic, and demographic factors. In the recent past, India has seen outbreaks of eight organisms of emerging and re-emerging diseases in various parts of the country, six of these are of zoonotic origin. Prevention and control of emerging infectious diseases will increasingly require the application of sophisticated epidemiologic and molecular biologic technologies, changes in human behaviour, a national policy on early detection of and rapid response to emerging infections and a plan of action. WHO has made several recommendations for national response mechanisms. Many of these are in various stages of implementation in India. However, for a country of size and population of India, the emerging infections remain a real and present danger. A meaningful response must approach the problem at the systems level. A comprehensive national strategy on infectious diseases cutting across all relevant sectors with emphasis on strengthened surveillance, rapid response, partnership building and research to guide public policy is needed.
引用
收藏
页码:18 / 30
页数:13
相关论文
共 50 条
  • [41] Emerging and re-emerging coronaviruses in pigs
    Wang, Qiuhong
    Vlasova, Anastasia N.
    Kenney, Scott P.
    Saif, Linda J.
    CURRENT OPINION IN VIROLOGY, 2019, 34 : 39 - 49
  • [42] Emerging and Re-Emerging Parasitic Infections of the Central Nervous System (CNS) in Europe
    Tunali, Varol
    Korkmaz, Metin
    INFECTIOUS DISEASE REPORTS, 2023, 15 (06) : 679 - 699
  • [43] Editorial emerging, re-emerging and drug-resistant infections: A global threat
    Jeljaszewicz, J
    ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES, 1999, 289 (01): : 1 - 7
  • [44] Emerging and re-emerging viral infections of the central nervous system in Australasia and beyond
    Wong, Kum Thong
    Hooi, Yuan Teng
    Tan, Soon Hao
    Ong, Kien Chai
    PATHOLOGY, 2025, 57 (02) : 230 - 240
  • [45] ASTICON 2024: Pioneering discussions on emerging and re-emerging sexually transmitted infections
    Pandhi, Deepika
    Gaurav, Vishal
    Ray, Subhojit
    INDIAN JOURNAL OF SEXUALLY TRANSMITTED DISEASES AND AIDS, 2024, 45 (02) : 174 - 191
  • [46] Re-emerging markets
    Goetzmann, WN
    Jorion, P
    JOURNAL OF FINANCIAL AND QUANTITATIVE ANALYSIS, 1999, 34 (01) : 1 - 32
  • [47] Reconsidering the history of type 2 diabetes in India: Emerging or re-emerging disease?
    Weaver, Lesley Jo
    Narayan, K. M. Venkat
    NATIONAL MEDICAL JOURNAL OF INDIA, 2008, 21 (06): : 288 - 291
  • [48] A Re-emerging Infection?
    Broy, Charles
    Williamson, Nicole
    Morris, Joseph
    SOUTHERN MEDICAL JOURNAL, 2009, 102 (03) : 299 - 300
  • [49] THE MOMENT TO RE-EMERGING
    BOMBONATTI, TA
    DEMORAES, JPP
    REVISTA BRASILEIRA DE MEDICINA, 1984, 41 (05) : 181 - 181
  • [50] Re-emerging Markets
    Goetzmann, William
    Jorion, Philippe
    JOURNAL OF FINANCE, 1997, 52 (03): : 1228 - 1228